Epidemiological aspects of uterine myomas among nulligest women at the general reference hospital of Panzi in Democratic Republic of the Congo

Sifa Balungwe, Raha Maroyi, Mpakanyi Joyeux, Mukango Omari, Mulongo Philémon, Nakiyo Olivier


Background: Myomas appear early in young women. The objective of this study was to evaluate the frequency of uterine myomas among nulligest women screened at the Panzi Hospital in South Kivu.

Methods: A cross-sectional study was conducted among women aged 20-35 years during the period from 01 August 2018 to 01 August 2019. Women were recruited for screening after their informed consent. Informed consent was sought prior to participation in the study. The main data collection tools were the survey questionnaire. An individual survey questionnaire was used for data collection, laboratory records and trans-abdominal ultrasound. Descriptive statistics were calculated.

Results: The median age of the women was 25 years. Positive myotomy was noted in 45.9% of cases. Submucosal and subperitoneal localization was predominant (48.6%). Young, unmarried, overweight women were the most common. The mean age of the menarche was 11.83±1.48 years. The consumption of red meat, green vegetables and alcohol was more noted. Exposure to the sun and wearing half-covered clothing were also noted. Abdominal and lumbar pain were the main symptoms observed. The majority used lightening products.

Conclusions: The study notes the early appearance of uterine myomas among women aged 20-35 years in our environment. A mass evaluation and screening of this population is necessary to establish prevention and the best management.


Epidemiology, Myomas, Nulligestes, Panzi hospital

Full Text:



Rongieres C. Épidémiologie du fibrome utérin: facteurs de risques et fréquence. Impact en Santé Publique: Recommendations pour la pratique clinique: Prise en charge des fibromes utérins. J Gynécol Obstét Biol Reprod. 1999;28(7):701-6.

Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM. Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci. 2011;11(2):271-8.

Claude R. Épidémiologie, facteurs de risque et symptomatologie des myomes utérins. Méd Reprod. 2009;11(2):118-22.

Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393-406.

Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed). 1986;293(6543):359-62.

Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology. 1996;440-2.

Cham LC, Mwembo TNA, Chenge MF, Kabulu KA, Otshudiongo TS , Kalenga MK. Etude des facteurs de risque associés à l’apparition des fibromyomes utérins à Lubumbashi, Congo. Revue Médicale des Grands Lacs. 2013;2(1):38-45.

Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, Willett WC, Hunter DJ. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 1998;9(5):511-7.

Rongières C. Épidémiologie du fibrome utérin : facteurs de risque et fréquence. Impact en santé publique. J Gynecol Obstet Biol Reprod. 1999;28:701-6.

Fernandez H, Chabbert Buffet N, Allouche S. Prévalence du fibrome utérin en France et impact sur la qualité de vie à partir d'une enquête menée auprès de 2500 femmes de 30-55ans [Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30-55 years]. J Gynecol Obstet Biol Reprod (Paris). 2014;43(9):721-7.

Magassouba D. Etude épidemio-clinique et thérapeutique du fibrome utérin dans le service de gynécologie obstétrique du CHU du point-g. Diss. Thèse de doctorat/Méd. Bamako, Mali. 2008.

Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynecol Obstet. 1995;51(2):127-31.